DBVT · DBV Technologies S.A.
$14.02
-0.01 (-0.07%)
At close · Aug 14
Market Cap
$4.15B
Shares
296.06M
DBV Technologies S.A. Earnings Call Transcripts
Every quarterly earnings call for DBV Technologies S.A. (DBVT) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
·
$
−$39.48M
'20 Q4
20-12-31
▼141.2%
$
−$30.65M
'21 Q2
21-08-02
▼68.2%
$1.32M
−$24.03M
'21 Q3
21-10-26
·
$2.93M
−$13.67M
'21 Q4
22-03-03
▼13.4%
$2.55M
−$16.71M
'22 Q1
22-05-02
▲56.8%
$2.07M
−$17.29M
'22 Q3
22-11-03
▼144.5%
$
$153.31M
'22 Q4
23-03-03
▼13.8%
$2.19M
−$20.56M
'23 Q1
23-04-20
▲49.6%
$2.29M
−$24.24M
'23 Q2
23-07-31
▲14.4%
$2.37M
−$16.74M
'23 Q3
23-10-31
·
$8.87M
$134.25M
'23 Q4
24-03-07
▼49.3%
$1.16M
−$33.12M
'24 Q2
24-07-30
▼54.8%
$1.07M
−$30.44M
'24 Q3
24-10-22
▲158.8%
$2.77M
−$33.16M
'25 Q3
25-12-16
▲12.5%
$900,000
−$47.60M
'26 Q1
26-04-30
LATEST
▼53.3%
$700,000
−$50.40M
'26 Q2
26-07-16
Conference
Investor event
2026-07-23
APA-AAI Conference 2026
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-07-16
DBV Technologies S.A. Q2 FY2026 Earnings Call
Positive tone
BLA submission status for Viaskin Peanut Patch (ages 4-7)
Comfort Toddlers study (ages 1-3)
FDA engagement and CMC/biostatistics work
Revenue
$700,000
▼ 53.3% YoY Diluted EPS
$-0.12
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-06-29
DBV Update Conference Call
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-05-28
Eastern Allergy Conference
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-05-19
H.C. Wainwright BioConnect Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-04-30
DBV Technologies S.A. Q1 FY2026 Earnings Call
Revenue
$900,000
▲ 12.5% YoY Diluted EPS
$-0.11
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-03-10
The Citizens Life Sciences Conference
No reported result — non-financial event
Audio
Transcript
Slides
Annual General Meeting
Investor event
2026-02-27
American Academy of Allergy, Asthma & Immunology Annual Meeting 2026
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q3
2025-12-16
VITESSE Topline Results Conference Call
Confident tone
Regulatory Path and BLA Submission
Phase 3 VITES Topline Results
Financing and Cash Runway
Revenue
$2.77M
▲ 158.8% YoY Diluted EPS
$-0.24
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2025-09-09
DBV Technologies to Participate in the H.C. Wainwright 27th Annual Global Investment Conference
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY24 · Q3
2024-10-22
DBV Technologies S.A. Q3 FY2024 Earnings Call
Revenue
$1.07M
▼ 54.8% YoY Diluted EPS
$-0.32
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-30
DBV Technologies S.A. Q2 FY2024 Earnings Call
Positive tone
COMFORT Toddlers supplemental safety study and FDA dialogue
EPITOPE Phase 3 in toddlers
Viaskin platform overview
Revenue
$1.16M
▼ 49.3% YoY Diluted EPS
$-0.34
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-03-07
DBV Technologies S.A. Q4 FY2023 Earnings Call
Positive tone
Viaskin Peanut efficacy and safety database
Regulatory pathway and BLA submissions
Toddler (1-3) program
Revenue
$8.87M*
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-31
DBV Technologies S.A. Q3 FY2023 Earnings Call
Revenue
$2.37M
▲ 14.4% YoY Diluted EPS
$-0.17
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-07-31
DBV Technologies S.A. Q2 FY2023 Earnings Call
Revenue
$2.29M
▲ 49.6% YoY Diluted EPS
$-0.26
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-04-20
DBV Technologies S.A. Q1 FY2023 Earnings Call
Revenue
$2.19M
▼ 13.8% YoY Diluted EPS
$-0.44
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-03
DBV Technologies S.A. Q4 FY2022 Earnings Call
Revenue
$*
▼ 144.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-03
DBV Technologies S.A. Q3 FY2022 Earnings Call
Revenue
$2.07M
▲ 56.8% YoY Diluted EPS
$-0.36
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-02
DBV Technologies S.A. Q1 FY2022 Earnings Call
Revenue
$2.55M
▼ 13.4% YoY Diluted EPS
$-0.60
Rev · 7q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-03-03
DBV Technologies S.A. Q4 FY2021 Earnings Call
Revenue
$2.93M*
Rev · 6q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-26
DBV Technologies S.A. Q3 FY2021 Earnings Call
Revenue
$1.32M
▼ 68.2% YoY Diluted EPS
$-0.88
Rev · 6q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-08-02
DBV Technologies S.A. Q2 FY2021 Earnings Call
Revenue
$
▼ 141.2% YoY Diluted EPS
$-1.12
Rev · 5q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2020-12-31
DBV Technologies S.A. Q4 FY2020 Earnings Call
Revenue
$*
Rev · 3q
Audio
Transcript
Slides
8-K10-K
Showing 1–23 of 23 earnings calls
Key facts
CIK
1613780
CUSIP
23306J309
13F (30d)
75 filings
74 filers
Visit website
Investor relations